U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07136363) titled 'RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry' on July 09.
Brief Summary: Justice-involved individuals face disproportionately high rates of stimulant use disorder and HIV, along with disrupted access to HIV treatment and prevention services like ART and PrEP. Contingency management (CM) is the most effective intervention for stimulant use, but its use in justice-involved populations has been limited by logistical and structural barriers. DynamiCare is an FDA-approved mobile app that delivers behavioral CM and has shown promise in reducing stimulant use, but its impact on HIV-related outcomes remai...